Nearly each and every clinical study brings with it particular supply challenges and circumstances. Patients and doctors rely on time critical management of investigational supply to ensure patient safety and compliance and it is the responsibility of sponsoring companies to ensure there is no interruption to supply lines.

Controlled substances carry a unique set of considerations that add logistical complexity and heighted accountability requirements to the already weighty task of patient demand forecasting. Almac’s Supply Chain Management group helps clients navigate these challenges, ensuring drug is always on hand when and where it is needed. This is one such case.